Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation

被引:34
|
作者
Rayya, F. [1 ]
Harms, J. [1 ]
Martin, A. P. [1 ]
Bartels, M. [1 ]
Hauss, J. [1 ]
Fangmann, J. [1 ]
机构
[1] Univ Leipzig, Clin Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany
关键词
D O I
10.1016/j.transproceed.2008.03.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A safe and effective preservation solution is a precondition for successful orthotopic liver transplantation (OLT). This study compared University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions in OLT. Patients and Methods. We retrospectively reviewed the medical records of 137 primary cadaveric. OLT performed between January 2003 and December 2006 at our institution. Sixty-eight grafts were harvested using UW and 69 using HTK. Recipients were managed similarly in regard to operative techniques and immunosuppression. We collected donor data including serum transaminases, serum sodium, ICU stay and assessed macroscopic liver quality. Recipient serum transaminases were collected on postoperative days 1, 7, 14, and 30. We compared biliary and vascular complications, as well as patient and graft survivals. Results. Mean serum bilirubin levels were slightly higher in the HTK group at 1,7,14, and 30 days after transplantation, whereas transaminases were higher in the UW group. Primary nonfunction occurred in 1 patient in each group. Retransplantation was performed in 5 patients in the UW and in 9 patients in the HTK group. Biliary complication rates were similar in the UW and HTK groups (22% and 17%, respectively). Six arterial complications occurred in the HTK (8.7%) and 2 in the UW group (2.9%; P < .05). Mean follow-up was 25 months. Graft survival at 1, 12, and 36 months was 90%, 78%, and 75% versus 90%, 71%, and 71% in the UW versus HTK groups, respectively. One-, 12-, and 36-month patient survival rates were 93%, 78%, and 75% versus 93%, 78%, and 78% in the UW versus HTK groups, respectively. Conclusions. There were no significant differences in graft and patient survivals between the 2 groups. Whereas the biliary complication rates were comparable in both groups, the arterial complications were clearly higher in the UW group (8.7% vs 2.9%; P < .05%). UW and HTK solutions seemed to be equally safe and effective in the preservation of liver grafts. The high incidence of arterial complications in the UW group requires further prospective studies.
引用
收藏
页码:891 / 894
页数:4
相关论文
共 50 条
  • [21] The Effect of Histidine-tryptophan-ketoglutarate Solution and University of Wisconsin Solution: An Analysis of the Eurotransplant Registry
    de Boer, Jacob D.
    Strelniece, Agita
    van Rosmalen, Marieke
    de Vries, Erwin
    Ysebaert, Dirk
    Guba, Markus
    Braat, Andries Erik
    Samuel, Undine
    TRANSPLANTATION, 2018, 102 (11) : 1870 - 1877
  • [22] HISTIDINE-TRYPTOPHAN-KETOGLUTARATE SOLUTION VS. UNIVERSITY OF WISCONSIN SOLUTION FOR DECEASED DONOR LIVER TRANSPLANTATION: ANALYSIS OF UNOS DATABASE
    Tellioglu, Gurkan
    Eghtesad, Bijan
    Alster, Joan M.
    Yao, David
    Lin, Songhua
    Fung, John
    LIVER TRANSPLANTATION, 2009, 15 (07) : S203 - S203
  • [23] Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation:: Results of a prospective study
    Testa, G
    Malagó, M
    Nadalin, S
    Treptow, B
    Paul, A
    Frilling, A
    Broelsch, CE
    LIVER TRANSPLANTATION, 2003, 9 (08) : 822 - 826
  • [24] Similar Survival and Complication Rates with Histidine-Tryptophan-Ketoglutarate Solution for Liver Preservation Compared to University of Wisconsin Solution
    Vanatta, J. M.
    Dean, A. G.
    Modanlou, K. A.
    Nair, S.
    Nezakatgoo, N.
    Campos, L.
    Eason, J. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 331 - 331
  • [25] Comparison of University of Wisconsin (UW) and Histidine-Tryptophan-Ketoglutarate (HTK) Solutions in Pediatric Liver Transplantation
    Mangus, Richard
    Schroering, Joel R.
    Hathaway, Taylor J.
    Kubal, Chandrashekhar A.
    TRANSPLANTATION, 2018, 102 : S791 - S791
  • [26] Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation A propensity score matching analysis from mainland China
    Xu, Xi
    Zhu, Yun-Feng
    Lv, Tao
    Zheng, Jin-Li
    Li, Yong-kun
    Zhang, Bo-Han
    Jiang, Li
    Yang, Jia-yin
    MEDICINE, 2020, 99 (51) : E23584
  • [27] Greater Hemodynamic Instability With Histidine-Tryptophan-Ketoglutarate Solution Than University of Wisconsin Solution During the Reperfusion Period in Living Donor Liver Transplantation
    Ko, J. S.
    Kim, G. S.
    Gwak, M. S.
    Yang, M.
    Kim, H. K.
    Shin, B. S.
    Kim, J. K.
    Lee, S. K.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (10) : 3308 - 3310
  • [28] COMPARISON OF HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) SOLUTION VERSUS UNIVERSITY-OF-WISCONSIN (UW) SOLUTION FOR ORGAN PRESERVATION IN HUMAN LIVER-TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED STUDY
    ERHARD, J
    LANGE, R
    SCHERER, R
    KOX, WJ
    BRETSCHNEIDER, HJ
    GEBHARD, MM
    EIGLER, FW
    TRANSPLANT INTERNATIONAL, 1994, 7 (03) : 177 - 181
  • [29] Comparison of University of Wisconsin and Histidine-Tryptophan-Ketoglutarate Solutions in Donation After Cardiac Death Liver Transplantation.
    Ertreo, M.
    Girlanda, R.
    Desai, C.
    Kishiyama, K.
    Hawksworth, J.
    Island, E.
    Matsumoto, C.
    Fishbein, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 735 - 736
  • [30] Comparison of University of Wisconsin and Histidine-Tryptophan-Ketoglutarate Solutions in Donation After Cardiac Death Liver Transplantation.
    Ertreo, M.
    Girlanda, R.
    Desai, C.
    Kishiyama, K.
    Hawksworth, J.
    Island, E.
    Matsumoto, C.
    Fishbein, T.
    TRANSPLANTATION, 2014, 98 : 735 - 736